-- U.S. RESEARCH ROUNDUP-Calpine Corp, Fidelity & Guaranty Life 
-- 
-- Mon May 12, 2014 02:57AM EDT
-- None



May 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Calpine Corp and Fidelity & Guaranty Life, on Monday.

HIGHLIGHTS * Calpine Corp <CPN.N>: RBC raises price target to $25 from $22; rating sector perform  * Fidelity & Guaranty Life <FGL.N>: Sandler O'Neill cuts price target to $25 from $26; buy  Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order. See bottom of the table for sector changes.   * Agrium Inc <AGU.N>: Susquehanna cuts price target to $112 from $115; rating positive  * Alcatel Lucent SA <ALU.N>: BMO cuts price target to $5 from $5.50; rating outperform * Amedisys Inc <AMED.O>: Piper Jaffray cuts price target to $12 from $13; rating neutral * Calpine Corp <CPN.N>: RBC raises price target to $25 from $22; rating sector perform * Clorox Co <CLX.N>: B.Riley cuts price target to $79 from $85; rating neutral  * DCP Midstream Partners <DPM.N>: RBC raises price target to $58 from $56; rating outperform * Dish Network <DISH.O>: Evercore Partners raises target to $72 from $67; rating overweight * Dish Network <DISH.O>: RBC raises price target to $69 from $62; rating outperform * Electronic Arts Inc <EA.O>: Stifel raises price target to $41 from $32; rating buy * Fidelity & Guaranty Life <FGL.N>: Sandler O'Neill cuts price target to $25 from $26; buy * Fresenius Medical <FMS.N>: Piper Jaffray cuts price target to $33 from $34; rating neutral